MedKoo Cat#: 465713 | Name: ATX-001
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ATX-001 is an ionizable lipid, which can be used as a lipid component in lipid nanoparticle (LNP) formulations for mRNA delivery. Its primary function is to enhance the intracellular delivery of nucleic acids by facilitating endosomal escape. While ATX-001 is not a therapeutic molecule per se, its bioactivity is characterized by its physicochemical properties and performance in in vitro and in vivo delivery systems. In published studies, LNPs containing ATX-001 demonstrated efficient mRNA delivery, with ~80–90% transfection efficiency in hepatocytes and other cell types, and robust protein expression following systemic administration in animal models. In mouse models, ATX-001-containing LNPs achieved liver-targeted mRNA expression at doses as low as 0.1 mg/kg, with favorable safety profiles, including minimal liver enzyme elevation and low pro-inflammatory cytokine induction.

Chemical Structure

ATX-001
ATX-001
CAS#1777792-33-2

Theoretical Analysis

MedKoo Cat#: 465713

Name: ATX-001

CAS#: 1777792-33-2

Chemical Formula: C40H74N2O5S

Exact Mass: 694.5318

Molecular Weight: 695.10

Elemental Analysis: C, 69.12; H, 10.73; N, 4.03; O, 11.51; S, 4.61

Price and Availability

Size Price Availability Quantity
5mg USD 350.00 Ready to ship
10mg USD 550.00 Ready to ship
25mg USD 1,150.00 Ready to ship
50mg USD 2,050.00 Ready to ship
100mg USD 3,650.00 Ready to ship
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
ATX-001; ATX001; ATX 001;
IUPAC/Chemical Name
di((Z)-non-2-en-1-yl) 8,8'-((2-((2-(dimethylamino)ethyl)thio)acetyl)azanediyl)dioctanoate
InChi Key
PSYGHBKNZFCYQB-ZDSKVHJSSA-N
InChi Code
InChI=1S/C40H74N2O5S/c1-5-7-9-11-13-21-27-34-46-39(44)29-23-17-15-19-25-31-42(38(43)37-48-36-33-41(3)4)32-26-20-16-18-24-30-40(45)47-35-28-22-14-12-10-8-6-2/h21-22,27-28H,5-20,23-26,29-37H2,1-4H3/b27-21-,28-22-
SMILES Code
O=C(CSCCN(C)C)N(CCCCCCCC(OC/C=C\CCCCCC)=O)CCCCCCCC(OC/C=C\CCCCCC)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Biological target:
ATX inhibitor 1 is a potent ATX (IC50=1.23 nM, FS-3 and 2.18 nM, bis-pNPP) inhibitor.
In vitro activity:
TBD
In vivo activity:
TBD
Solvent mg/mL mM
Solubility
DMSO 250.0 359.66
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 695.10 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Balupuri A, Lee MH, Chae S, Jung E, Yoon W, Kim Y, Son SJ, Ryu J, Kang DH, Yang YJ, You JN, Kwon H, Jeong JW, Koo TS, Lee DY, Kang NS. Discovery and optimization of ATX inhibitors via modeling, synthesis and biological evaluation. Eur J Med Chem. 2018 Mar 25;148:397-409. doi: 10.1016/j.ejmech.2018.02.049. Epub 2018 Feb 17. PMID: 29477073.
In vitro protocol:
1. Balupuri A, Lee MH, Chae S, Jung E, Yoon W, Kim Y, Son SJ, Ryu J, Kang DH, Yang YJ, You JN, Kwon H, Jeong JW, Koo TS, Lee DY, Kang NS. Discovery and optimization of ATX inhibitors via modeling, synthesis and biological evaluation. Eur J Med Chem. 2018 Mar 25;148:397-409. doi: 10.1016/j.ejmech.2018.02.049. Epub 2018 Feb 17. PMID: 29477073.
In vivo protocol:
TBD
Anzalone, A., Manno, C. I., Ferrera, F., Barbagallo, G., Cali, C., Yingmei, G., & Giustolisi, F. (1994). A VME-Macintosh data acquisition system with ECL readout. IEEE transactions on nuclear science, 41(1), 69-76. Dammer, E. B., Shantaraman, A., Ping, L., Duong, D. M., Gerasimov, E. S., Ravindran, S. P., ... & Johnson, E. C. (2023). Proteomic network analysis of Alzheimer’s disease cerebrospinal fluid reveals alterations associated with APOE ε4 genotype and atomoxetine treatment. MedRxiv. Wei, P. S., Thota, N., John, G., Chang, E., Lee, S., Wang, Y., ... & Mei, K. C. (2024). Enhancing RNA-lipid nanoparticle delivery: organ-and cell-specificity and barcoding strategies. Journal of Controlled Release, 375, 366-388.